By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Genome sequencing is the process of identifying the complete DNA sequence of an organism's genome. This includes chromosomal DNA, DNA in mitochondria as well as DNA in the chloroplast for plants. Its importance cannot be undermined, and it is all set to take personalised medicine to a whole new level. The Human Genome Project (HGP) that was launched in the year 1990 flung open the doors of what many predicted would be 'Biology's century'. Since then, the corpus of information has grown from some error-filled genome sequences to a complete account of the genetic variation of lakhs of individuals around the world, and an increasing number of tools and technologies to study it.
The primary purpose of sequencing the human genome is to figure out the order of DNA nucleotides, or bases, in the genome the order of As, Cs, Gs, and Ts that make up an organism's DNA. Its importance in the modern world cannot be undermined.
Genome sequencing is important and is essential for disease anticipation and prevention. In the near future, we will see more people obtaining their own whole-genome sequence. Let us look at a few benefits.
The science and medicine communities around the world are just starting to seize the transformative opportunities that genome sequencing offers. With further investment in infrastructure and technology required for sequencing, the healthcare sector will be transformed completely. Higher precision offered by genome sequencing in disease identification reduces health costs and adverse reactions from unnecessary treatments. The sequencing technology will also have a major impact on the national economy, not only by reducing errored treatments, decreasing costs of treating diseases but also by creating new industries of valuable medical information.
The cost of sequencing the genome has dropped from USD 2.7 billion in 2003 to USD 1500 in 2018. Additionally, many people are using Direct-to-Consumer genetic tests to analyze certain genome regions at a cost of less than USD 100. The scope of genome sequencing is growing with the reducing costs and increasing accessibility. The ever-increasing capacity for accurate sequencing is also leading to the development of effective and targeted treatment strategies.
(This article is authored by Subhamoy Dastidar, Co-Founder & Director, Lilac Insights)
Follow us on